http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4013502-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30beaaa993ebfd38cfa2df185ff97bb6
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-10
filingDate 2020-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c3378f299a68992e0e2a99992b1ada8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6a6965e0af929315af8514f206a3a7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_255ef357d247333cca64d697df8a6b0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3b97fe5d8f5a18f3604feebc30f8a41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b91945fbe0bdb4ddf8d5ed2b3756e8d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5db76fecf9e41501b571e3edd18d2b2d
publicationDate 2022-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-4013502-A1
titleOfInvention Process for the preparation of a pyrimidino-diazepine derivative
abstract In one aspect, the invention relates to a process for preparing a compound of formula (XII), wherein PG is a protecting group, or a compound of formula (XI), comprising the steps of: (i) treating a compound of formula XIII, wherein PG is a protecting group, with N- methylpiperazine to form a compound of formula XII, wherein said compound of formula XII is in the form of a mixture of cis and trans isomers; (ii) combining the mixture formed in step (i) with an organic solvent and heating the solvent mixture so formed; (iii) isolating the trans-isomer of the compound of formula XII from the solvent mixture formed in step (ii); and (iv) optionally treating said trans-isomer of the compound of formula XII with an acid to form a compound of formula XI; and isolating said compound of formula XI. Further aspects of the invention relate to processes for preparing pyrimido-diazepinone derivatives using the above process and intermediates.
priorityDate 2019-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226478724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4428483
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42640739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226478723
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227436437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226478725
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7708
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226440013
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1512535
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227214903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID521266
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14615292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226920420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66746050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15459053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135399369
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21864113
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17986852
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226489379
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57741209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227268628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226403335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53903450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227007983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87066635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66877333

Total number of triples: 70.